- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04220567
Effectiveness of Exercise and Patient-centred Education on Fibromyalgia
Is a Combined Programme of Exercise and Patient-centred Education More Effective Than Exercise Alone in Individuals With Fibromyalgia? A Randomised Controlled Trial
This study aims to compare the effects of an eight-week exercise and patient-centred education programme with eight-week exercise alone programme on disability, pain intensity, health-related quality of life and patient global impression of change.
A prospective, parallel, double-blinded and multi-centre randomised controlled trial will be carried out.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Setúbal, Portugal, 2914-503
- Recruiting
- Carmen Caeiro
-
Contact:
- Carmen Caeiro, PhD
- Phone Number: 5382 00351 265 709 382
- Email: carmen.caeiro@ess.ips.pt
-
Contact:
- Patrícia Falcão, BSc Hons
- Phone Number: 5382 00351 265 709 382
- Email: patricia.falcao@ess.ips.pt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016)
Exclusion Criteria:
- Presence of uncontrolled medical disorders (cardiovascular/ metabolic/ neurological/ renal)
- Presence of active oncological disease (or until 5 years and undergoing treatment)
- Presence of inflammatory rheumatic diseases other than fibromyalgia
- Presence of inflammatory osteoarticular disease or severe osteoarthritis (grade IV de Kellgren - Lawrence Classification of Osteoarthritis)
- Previous orthopaedic (column or lower limb) or cardiothoracic surgery in the year before;
- Disability not compatible with the exercise practice required
- Pregnancy
- Attendance to a physiotherapy programme including exercise in the previous three months
- Difficulty in written communication that prevent the fulfilment of self-reported questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Exercise and Patient-centred education
|
An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist. Exercise will be carried out three times a week. Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations). Patient-centred Education will follow the principles of transformative learning & incorporate patients' narratives. It will precede 9 of the 24 exercise sessions and be delivered by the same physiotherapist |
ACTIVE_COMPARATOR: Exercise
|
An eight-week programme based on 24 sessions of exercise supervised by a physiotherapist.
Exercise will be carried out three times a week.
Once a week the exercise session is performed autonomously by patient at home (according to the physiotherapist's recommendations).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity
Time Frame: Baseline
|
Measured using the Numeric Pain Rating Scale, NPS, 0-10
|
Baseline
|
Pain intensity
Time Frame: 4 weeks
|
Measured using the Numeric Pain Rating Scale, NPS, 0-10
|
4 weeks
|
Pain intensity
Time Frame: 8 weeks
|
Measured using the Numeric Pain Rating Scale, NPS, 0-10
|
8 weeks
|
Pain intensity
Time Frame: Follow-up 3 months
|
Measured using the Numeric Pain Rating Scale, NPS, 0-10
|
Follow-up 3 months
|
Disability and Impact of Fibromyalgia
Time Frame: Baseline
|
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
|
Baseline
|
Disability and Impact of Fibromyalgia
Time Frame: 4 weeks
|
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
|
4 weeks
|
Disability and Impact of Fibromyalgia
Time Frame: 8 weeks
|
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
|
8 weeks
|
Disability and Impact of Fibromyalgia
Time Frame: Follow-up 3 months
|
Measured using the Revised Fibromyalgia Impact Questionnaire, FIQr, 0-100
|
Follow-up 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuropathic components in pain
Time Frame: Baseline
|
Measured using the painDETECT Questionnaire
|
Baseline
|
Health-related Quality of Life
Time Frame: Baseline
|
Measured using the EuroQol 5D 3L, EQ 5D-3L
|
Baseline
|
Health-related Quality of Life
Time Frame: 4 weeks
|
Measured using the EuroQol 5D 3L, EQ 5D-3L
|
4 weeks
|
Health-related Quality of Life
Time Frame: 8 weeks
|
Measured using the EuroQol 5D 3L, EQ 5D-3L
|
8 weeks
|
Health-related Quality of Life
Time Frame: Follow-up 3 months
|
Measured using the EuroQol 5D 3L, EQ 5D-3L
|
Follow-up 3 months
|
Patients' perception of improvement or decline in clinical status
Time Frame: 4 weeks
|
Measured using the The Patient Global Impression of Change Scale, PGIC, 1-7
|
4 weeks
|
Patients' perception of improvement or decline in clinical status
Time Frame: 8 weeks
|
Measured using the Patient Global Impression of Change Scale, PGIC, 1-7
|
8 weeks
|
Patients' perception of improvement or decline in clinical status
Time Frame: Follow-up 3 months
|
Measured using the Patient Global Impression of Change Scale, PGIC, 1-7
|
Follow-up 3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IPSetubalESS_SHARE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Spaulding Rehabilitation HospitalNot yet recruiting
-
Cairo UniversityNot yet recruiting
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
University of UtahTerminated
-
State University of New York - Upstate Medical...CompletedFibromyalgia, PrimaryUnited States
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
Clinical Trials on Experimental: Exercise and Patient-centred education
-
Glasgow Caledonian UniversityNorthumbria University; NHS Greater Glasgow and Clyde; University of Glasgow; Chief...CompletedPeripheral Arterial Disease | Intermittent ClaudicationUnited Kingdom
-
Hasan Kalyoncu UniversityRecruitingHeadache | Temporomandibular DisordersTurkey
-
Oslo University HospitalUnknownHip OsteoarthritisNorway
-
Ullevaal University HospitalUnknownExercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. Long-term Follow-up.Hip OsteoarthritisNorway
-
Riphah International UniversityCompletedPulmonary Arterial HypertensionPakistan
-
Ullevaal University HospitalNorwegian Foundation for Health and RehabilitationCompletedHip OsteoarthritisNorway
-
Hacettepe UniversityEnrolling by invitationCongenital Heart DiseaseTurkey
-
Bayero University Kano, NigeriaCompletedNonspecific Chronic Low Back PainNigeria
-
Bayero University Kano, NigeriaCompleted
-
Aarhus University HospitalUniversity of Aarhus; VIA University College; Research Unit for General Practice... and other collaboratorsRecruiting